Triple
T22457047
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH E8 General Considerations for Clinical Trials |
E555142
|
entity |
| Predicate | relatedTo |
P37
|
FINISHED |
| Object | ICH E9 Statistical Principles for Clinical Trials |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ICH E9 Statistical Principles for Clinical Trials | Statement: [ICH E8 General Considerations for Clinical Trials, relatedTo, ICH E9 Statistical Principles for Clinical Trials]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ICH E9 Statistical Principles for Clinical Trials Context triple: [ICH E8 General Considerations for Clinical Trials, relatedTo, ICH E9 Statistical Principles for Clinical Trials]
-
A.
ICH E8 General Considerations for Clinical Trials
ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
-
B.
ICH E6 Good Clinical Practice
ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
-
C.
ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
ICH M3(R2) is an international guideline that harmonizes requirements for nonclinical safety studies needed to support the initiation and progression of human clinical trials and the marketing authorization of pharmaceuticals.
-
D.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
E.
Statistics in Biopharmaceutical Research
Statistics in Biopharmaceutical Research is a peer-reviewed journal focusing on the development and application of statistical methods in pharmaceutical, biotechnology, and medical product research.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: ICH E9 Statistical Principles for Clinical Trials Target entity description: ICH E9 Statistical Principles for Clinical Trials is an international guideline that defines key statistical concepts and methodologies to ensure the design, analysis, and interpretation of clinical trial data are scientifically sound and regulatory compliant.
-
A.
ICH E8 General Considerations for Clinical Trials
ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
-
B.
ICH E6 Good Clinical Practice
ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
-
C.
ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
ICH M3(R2) is an international guideline that harmonizes requirements for nonclinical safety studies needed to support the initiation and progression of human clinical trials and the marketing authorization of pharmaceuticals.
-
D.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
E.
Statistics in Biopharmaceutical Research
Statistics in Biopharmaceutical Research is a peer-reviewed journal focusing on the development and application of statistical methods in pharmaceutical, biotechnology, and medical product research.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e51fdec8190adfdf9f8a6362221 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15b7c428c8190847a259eef969525 |
completed | April 29, 2026, 1:14 a.m. |
Created at: April 16, 2026, 8:48 p.m.